SPONSOR
Minovia Therapeutics Ltd.
Total Trials
2
Recruiting
2
Phases
Phase 2
Minovia Therapeutics Ltd. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Mitochondrial Diseases, Pearson Syndrome, Primary Mitochondrial Diseases.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Minovia Therapeutics Ltd.
How many clinical trials has Minovia Therapeutics Ltd. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Minovia Therapeutics Ltd., of which 2 are actively recruiting participants. These trials cover conditions including Mitochondrial Diseases, Pearson Syndrome, Primary Mitochondrial Diseases. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Minovia Therapeutics Ltd. research focus on?
Minovia Therapeutics Ltd. clinical trials span Mitochondrial Diseases, Pearson Syndrome, Primary Mitochondrial Diseases. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Minovia Therapeutics Ltd. clinical trial?
To participate in a Minovia Therapeutics Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Minovia Therapeutics Ltd. trials with current recruitment status updated daily.
Clinical Trials by Minovia Therapeutics Ltd.
NCT06017869 Phase 2
Recruiting
Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)
Mitochondrial Diseases
NCT06474104
Recruiting
Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers
Primary Mitochondrial Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology